HCV communication within ego-centric networks of men and women who inject drugs
Marisa Felsher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Carl A. Latkin(Johns Hopkins University), Karin E. Tobin, Mark Sulkowski(Johns Hopkins University)
Cited by 8
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694